Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Filings indexed 1,319 across all filing types
Latest filing 2025-04-11 Major Shareholding Noti…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Citigroup Inc. regarding PureTech Health PLC. This is a regulatory requirement for shareholders to disclose when their voting rights cross specific thresholds. This fits the definition of a Major Shareholding Notification (MRQ).
2025-04-11 English
PRTC Appoints Peel Hunt Joint UK Corporate Broker
Regulatory Filings Classification · 98% confidence The document is a short press release (under 5,000 characters) announcing the appointment of a new Joint UK Corporate Broker (Peel Hunt). It does not fit into specific categories like financial reports, dividend announcements, or director dealings. As it is a general corporate announcement distributed via the RNS (Regulatory News Service) platform that does not fall into a more specific category, it is classified as a general regulatory filing.
2025-04-09 English
6-K
Regulatory Filings
2025-04-07 English
Statement re Possible Offer
M&A Activity Classification · 100% confidence The document is an official announcement regarding press speculation about a potential acquisition of PureTech Health plc by Nordic Capital. It explicitly references 'Rule 2.4 of the City Code on Takeovers and Mergers' and discusses a 'possible cash offer'. This falls squarely under the definition of M&A activity (takeover bids/proposals).
2025-04-07 English
PRTC's Seaport Adds Finance/Operations Exec to BOD
Regulatory Filings Classification · 98% confidence The document is a press release distributed via RNS (Regulatory News Service) by PureTech Health PLC. The core content announces that PureTech's Founded Entity, Seaport Therapeutics, has appointed a new director (Robert J. Hombach) to its Board of Directors and as Audit Committee Chair. This announcement concerns changes in the company's board and senior governance structure. This directly aligns with the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific content is about management changes, making MANG the most precise classification over the general RNS fallback.
2025-03-11 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content discloses the 'Total Voting Rights and Share Capital' as of a specific month-end date (28 February 2025), which is a mandatory regulatory disclosure under DTR 5.6.1. This type of general regulatory announcement that doesn't fit a more specific category (like Director's Dealing or Major Shareholding Notification) is best classified as a general Regulatory Filing, which corresponds to the RNS code.
2025-03-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.